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Abstract
Background: Right ventricular hypertrophy (RVH) is an important complication of chronic lung
disease. However, the signal transduction pathways involved as well as the physiological changes to
the right ventricle have not been investigated. Emphysema was produced in male, Syrian Golden
hamsters by intra-tracheal instillation of 250 IU/kg elastase (Emp, n = 17). Saline treated animals
served as controls (Con, n = 15).
Results: Nine months later, Emp hamsters had 75% greater lung volume, and evidence of RVH at
the gross and myocyte level (RV:tibia length Emp 6.84 ± 1.18 vs. Con 5.14 ± 1.11 mg/mm; myocyte
cross sectional area Emp 3737 vs. Con 2695 µm2), but not left ventricular hypertrophy. Serial
echocardiographic analysis from baseline to nine months after induction of emphysema revealed
increasing right ventricular internal dimension and decreased pulmonary artery acceleration time
only in Emp hamsters. There was an increase in translocation of PKC β I and PKC ε  from cytosolic
to membranous cell fractions in RV of Emp hamsters. Phosphorylation of PKC ε  was unchanged.
Translocation of PKC α  and β II were unchanged. Emp animals had a 22% increase in phospho-ERK
1/2, but no change in levels of total ERK 1/2 compared to Con.
Conclusion:  These data suggest that PKC β I,  ε  and ERK 1/2 may play a role in mediating
compensated RVH secondary to emphysema and may have clinical relevance in the pathogenesis
of RVH.
Background
Emphysema affects nearly 3 million people and is respon-
sible for nearly 16,000 deaths per year in the United States
[1]. Pulmonary parenchymal disease may lead to
increased pulmonary vascular resistance and elevated pul-
monary arterial pressures. The development of
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pulmonary hypertension and RVH are markers of
increased mortality in emphysema [2]. The problem of
cor pulmonale is quite important since in the United
States approximately 20% of hospital admissions for
heart failure are caused by right heart failure. However,
the precise changes in pulmonary hemodynamics, right
ventricular structure and function in emphysema, as well
as the underlying cell signaling pathways activated in this
condition, remain unknown. We investigated these
parameters using a hamster model in which emphysema
is produced by intratracheal administration of elastase.
This causes a reproducible and progressive form of bul-
bous emphysema characterized by increased lung volume
and pulmonary parenchymal pathology similar to that of
humans with emphysema [3].
Even though many studies have identified a critical role
for many protein kinase C isoforms (PKC α , β I, β II, δ , ε )
and extracellular regulated kinase (ERK) 1/2 in the patho-
genesis of left ventricular hypertrophy, very few studies
have examined these kinases in RVH. It has been previ-
ously reported that PKC α , β I, and δ  activation is increased
in RVH due to pulmonary artery constriction[4], and PKC
α  and δ  activation increased during RVH induced by vol-
ume overload[5]. In contrast, there have been no studies
to our knowledge regarding the role of ERK1/2 during
RVH.
Given the numerous human and animal studies identify-
ing PKC and ERK1/2 as critical mediators of left ventricu-
lar hypertrophy [6-12], and the aforementioned studies,
we hypothesized that ERK1/2 and differential PKC iso-
forms would be activated in RVH secondary to emphy-
sema. The progression of changes in right ventricular size
and function over time using a noninvasive ultrasound
approach, as well as pulmonary hemodynamics were also
determined. We report here that hamsters developed
moderate, well-compensated RVH characterized by an
absence of fibrosis, normal contractility, and mildly
increased pulmonary pressure after nine months with
emphysema. Furthermore, hamsters with emphysema
had marked translocation of PKC β I and PKC ε  to mem-
branous cell fractions, along with increased ERK 1/2
phosphorylation.
Results
Total heart weights and RV weights were greater in Emp
animals than Con, with the increased total heart weight in
Emp being entirely due to the increase in RV mass (Table
1, Figure 1A &1C). Myocyte cross sectional area was
greater in Emp right ventricles compared to controls
(3737 µM2 vs. 2695 µM2) (Figure 1D) as was myocyte
perimeter length (Table 1). The presence of lung pathol-
ogy and air trapping in the Emp animals was evidenced by
a 75% increase in lung volume (Table 1).
Echocardiographic assessment documented progressive
right ventricular enlargement over time in the Emp ham-
sters, with significantly greater right ventricular internal
dimension (RVID) vs. Con after nine months of emphy-
sema (Figure 2B). Histological examination of heart cross
sections showed no differences in fibrosis in either right
or left ventricles of Emp hamsters compared to Con (Fig-
ure 1B).
There was a significant correlation (r = 0.68) between the
RVID and lung volume measured (Figure 2C). Only trivial
amounts of tricuspid valve regurgitation were found in
any hamster at any time point and there was no detectable
pulmonary insufficiency. Thus, RV and pulmonary artery
pressures could not be estimated from the noninvasive
studies. Right ventricular outflow tract (RVOT) Doppler
Table 1: Organ weights, right ventricle analysis, and heart rates of hamsters with emphysema.
Control n Emphysema n
Initial Body Wt. (g) 113 ± 9 15 112 ± 6 17
Final Body Wt. (g) 133 ± 16 15 132 ± 20 17
Lung Volume (mL) 1.43 ± 0.20 15 2.51 ± 0.68* 17
Heart Wt. (mg) 544 ± 78 15 616 ± 90* 17
Heart:tibia length (mg:mm) 19.4 ± 2.6 15 21.2 ± 3.2 17
RV Wt. (mg) 145 ± 33 8 197 ± 34* 10
Heart Rate (beats/min) 192 ± 30 7 190 ± 27 7
RVSP 22 ± 2 7 26 ± 2* 7
RVEDP 0.4 ± 0.4 7 0.9 ± 0.9 7
+dP/dT 1016 ± 162 7 1214 ± 139* 7
-dP/dT -827 ± 142 7 -944 ± 114 7
Myocyte perimeter length (µM) 250 ± 11 5 302 ± 18* 5
*p ≤  0.05 RV, right ventricle; RVSP, right ventricular systolic pressure (mmHg); RVEDP, right ventricular end-diastolic pressure (mmHg); dP/dt, first 
derivative of pressure (mmHg/sec).BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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profiles were adequate for analysis in all animals. RVOT
acceleration time progressively shortened in the Emp ani-
mals and was significantly shorter compared to the Con
after nine months (Figure 3A,B). There was an inverse cor-
relation between the RVOTAT and RVID (r = - 0.68) at
nine months (Figure 3C).
There was a mild, but statistically significant increase in
right ventricular systolic pressure (RVSP) after nine
months of emphysema (Figure 4A, Table 1). There was a
strong positive correlation (r = 0.65) between RVSP and
RVID (Figure 4C). Emp hamsters also had a slightly
greater +dP/dt and similar -dP/dt compared to the Con
group, implying a mostly normal pattern of RV contrac-
tion & relaxation (Figure 4B, Table 1).
No differences were detected in translocation of PKC iso-
forms α  and β II between Emp and Con hamsters, as evi-
denced by the unchanged membrane-to-cytosol ratio
(Figure 5A,B). There was a shift in distribution of PKC β I
to membrane fractions resulting in an increase in translo-
cation (Figure 5A,B). There was also a 95% increase in
translocation of PKC ε  in the RV of Emp hamsters (Figure
5A,B). The increase in PKC ε  translocation was character-
ized by unchanged cytosolic fractions in coordination
with a 110% increase in PKC ε  found in the membrane
fraction (Figure 5A,B). The marked increase in membrane
levels of PKC ε  indicates that protein expression of ε  was
also increased, with a greater proportion of that isoform
being distributed in the membrane fractions. The average
translocation index (membrane:cytosol) was 1.14 ± 0.11
for Con and 2.22 ± 0.33 for Emp animals. Levels of phos-
phorylated PKC ε  from whole RV homogenates were quite
variable, but means were similar between Con and Emp
animals (Figure 5C). Increased levels of PKC ε  membrane
translocation, however, suggest that more of the phospho-
rylated PKC ε  may be in the membrane fraction of Emp
hamsters rather than the cytosol. PKC β I phosphorylation
was not determined in this study since antibodies specific
for phosphorylated PKC β I are not commercially
available.
RV homogenates from Emp hamsters had increased phos-
pho-ERK1/2 levels, resulting in a 34% increase in the ratio
of phospho ERK1/2 to ERK1/2 (Figure 6). Total JNK levels
were similar between Con and Emp groups (data not
shown). Phospho-JNK was not detected in RV homoge-
nates from either Con or Emp hamsters. This result most
likely reflects insensitivity of the antibody used against
hamster phospho-JNK and should not be taken as evi-
dence that JNK is unimportant in the development of
RVH.
Discussion
Despite the morbidity and mortality, associated with right
heart failure, the pathogenesis of right ventricular hyper-
trophy has been studied much less than left ventricular
disease. Evidence from clinical observations and animal
studies suggest that the right ventricle does not respond to
stress in precisely the same fashion as the left ventricle.
Most patients with L-transposition of the great arteries, a
condition in which the anatomic right ventricle serves as
the systemic ventricle from birth, eventually develop
severe RV failure. This usually occurs before the age of 30
[13]. Thus, clinical evidence suggests that the genetic pro-
gram of the right ventricle is not designed to face an
increased work load even when the adaptation is very
gradual. Several animal studies also show different
responses of the right and left ventricles to pressure over-
load [14,15].
The most commonly studied small animal model of right
heart failure is the monocrotaline treated rat. Monocrota-
line injection produces severe pulmonary hypertension
over a period of several weeks [16]. The elastase treated
hamster may be more closely related to clinical features of
RVH secondary to emphysema than other models using
pulmonary hypertension/overload for two reasons. First,
the lung injury develops much more slowly with different
degrees of hypoxia leading to varying levels of pulmonary
artery constriction. This is substantiated by only modest
echocardiographic changes (increased RVID and
shortened RVOTAT) found in this study in the first six
months after elastase treatment (Figure 2B, 3B). Second,
the degree of pulmonary hypertension is less severe than
that which is usually seen after monocrotaline injection
where pulmonary pressure often exceeds 65 mmHg
within six weeks [16,17]. Clinically, most patients with
chronic obstructive pulmonary disease such as emphy-
sema have mild or moderate pulmonary hypertension at
rest [18], perhaps more similar to the mild increases in RV
systolic pressure found in Emp animals in the present
study. There have been several hypotheses to explain the
development of pulmonary hypertension in the setting of
emphysema, with hypoxic vasoconstriction being the
most supported mechanism [19]. Other factors such as in
situ thrombosis and polycythemia may play a role as well
[18].
In the present study RV from the EMP animals had slightly
increased +dP/dt, normal -dP/dt, and lack of fibrosis in
histological sections, together indicating presence of com-
pensated RVH. Despite these changes, we were unable to
detect anything more than trivial degrees of tricuspid
regurgitation in the Emp hamsters. Interestingly, even in
the absence of tricuspid regurgitation, the RVOT accelera-
tion time showed an inverse correlation with RV size.
Based on these data it seems likely RVOT Doppler spectraBMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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A. Gross cross sections of hearts from hamsters with emphysema and age matched controls Figure 1
A. Gross cross sections of hearts from hamsters with emphysema and age matched controls. Hamsters with emphysema dem-
onstrate a range of RV free wall thickness and chamber dilation, however all are larger than controls. Reference scale on bot-
tom of picture is in mm. B. Histological sections of hearts were stained with Masson's Trichrome to visualize collagen content. 
No significant evidence of fibrosis were seen in Emp hamsters compared to Con. C. Right ventricle:tibia length is greater in 
Emp animals compared to Con. D. Myocytes cross sectional area was greater in right ventricles from Emp animals compared 
to Con. Data collected from individual myocytes (524 control, 555 Emp) collected from 7 Con and 5 Emp hamsters. Con, con-
trol; Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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may be a useful surrogate marker for determining the
presence of early or mild forms of pulmonary hyperten-
sion in the absence of tricuspic valve regurgitation.
This is the first study to demonstrate PKC β I, PKC ε  and
ERK1/2 activation in RVH secondary to emphysema. In
total we evaluated PKC α , β I, β II, δ , and ε  in this study as
these isoforms have all been implicated in the
pathogenesis of cardiac hypertrophy and ventricular dys-
function in cell culture, insult driven, and transgenic ani-
mal models[6,7,12,20]. The unchanged levels of cytosolic
PKC ε  coupled with a marked increase in membrane PCK
ε  indicate that expression levels were upregulated in Emp.
Thus, it appears right ventricular PKC ε  response to
emphysema is more complex than a simple re-distribu-
tion of basal levels, and involves greater production of
PKC ε  protein. With specific regard to PKC ε , several lines
of evidence support a role for PKC ε  in the development
of cardiac hypertrophy as reviewed by Sabri et al. [21].
Recent studies using transgenic mice with cardiac specific
overexpression of PKC ε  now suggest that low to moderate
PKC ε  activation, characterized by a 6 fold increase in
translocation [7] or 228% increase in PKC activity [22]
result in physiological cardiac hypertrophy with normal
cardiac function. In contrast, a high degree of PKC ε
activation, characterized by a 34 fold increase in
A. An example of the right ventricular internal diastolic dimension (RVID) as measured from the apical four-chamber view  (RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle) Figure 2
A. An example of the right ventricular internal diastolic dimension (RVID) as measured from the apical four-chamber view 
(RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle). B. RVID was measured at baseline, 3, 6, 8 and 9 months 
in the Emp group and at baseline and nine months in the Con group. Note the significant RV enlargement over time in the Emp 
group. RVID in the Emp group was significantly larger than the Con group after nine months (*p ≤  0.05). C. There is a signifi-
cant positive linear correlation between RVID and lung volume for both the Emp and Con groups after nine months. Con, con-
trol; Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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translocation [7] or 452% increase in activity [22] result in
pathological hypertrophy characterized by poor contrac-
tility and heart failure. Furthermore, it has also been
shown that moderate activation of PKC ε  in vivo by it's
RACK (Receptor for Activated C Kinase) increases translo-
cation of PKC ε  by only 20% and results in mild compen-
sated hypertrophy [23]. It is thought that in the case of
excessive PKC ε  activation, heart failure is mediated by
PKC ε  induced cross activation of PKC β II, which has been
previously demonstrated to cause a heart failure pheno-
type in transgenic mice [9,12]. The present study found a
95% increase in PKC ε  translocation, but no increase in
PKC β II in the RV of Emp hamsters. This appears to fall in
to the range of "moderate" levels of PKC ε  translocation
that have been associated with compensated/physiologi-
cal hypertrophy in the aforementioned studies. In contrast
with our results, another study using rats subjected to pul-
monary artery constriction for 3 weeks found greater
membrane levels of PKC α  and δ , but no change in PKCε
[4]. It is possible that greater RV systolic pressure after pul-
A. Representative examples of right ventricular outflow tract Doppler flow patterns in Con and Emp hamsters nine months  after elastase or vehicle treatment Figure 3
A. Representative examples of right ventricular outflow tract Doppler flow patterns in Con and Emp hamsters nine months 
after elastase or vehicle treatment. A more symmetric contour of the Doppler spectrum is seen in the Con group as compared 
to the Emp animals which show an earlier peak flow velocity. The points used for measurement of RVOT acceleration time are 
indicated. B. Right ventricular outflow tract Doppler spectra were measured at baseline, 3, 6, 8 and 9 months in the Emp group 
and at baseline and nine months in the Con group. Note the significant decrease in pulmonary artery acceleration time (PAAT) 
over time in the Emp group. Right ventricular outflow tract acceleration time in the Emp group was significantly shorter that 
the Con group after nine months (*p ≤  0.05 vs. Con). C. Right ventricular internal diastolic dimension (RVID) vs. PAAT for 
both the Emp and Con groups after nine months. Note the significant inverse linear correlation between RVID and PAAT in 
the Emp hamsters. Con, control; Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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monary constriction (44 mmHg in pulmonary constricted
rats vs. 26 mmHg in Emp hamsters) resulted in differen-
tial activation of PKC isoforms. Other differences that
may have contributed to these contrasting results include
the duration of the study (3 weeks vs. 9 months), the
degree of RVH developed (much less in Emp hamsters),
and the species studied.
An analysis of total PKC ε  phosphorylation in whole RV
homogenates found similar levels in both Emp and Con
hamsters, however, these samples also demonstrated sig-
nificant variation in phosphorylation state among indi-
vidual hamsters. This may be due to the phospho specific
PKC ε  antibody used, which was derived against a human
epitope, and may have had reduced specificity against the
hamster protein. We used an antibody that recognized
PKC ε  phosphorylated at Ser 729, an amino acid in the C-
terminal hydrophobic motif. Ser 729 is autophosphor-
ylated by PKC ε  itself following PDK-1 dependent
phosphorylation of Thr 566[24]. PKC ε  phosphorylated at
A. Representative examples of right ventricular pressure tracing in Con (n = 7) and Emp (n = 7) hamsters Figure 4
A. Representative examples of right ventricular pressure tracing in Con (n = 7) and Emp (n = 7) hamsters. Right ventricular 
systolic pressure (RVSP) was significantly higher in the Emp group. B. First derivative of RV pressure (dP/dt) obtained in Con (n 
= 7) and Emp (n = 7) hamsters. There was a higher +dP/dt in the Emp group vs. Con. C. There is a significant positive linear 
correlation between RVID and RVSP in Con and Emp groups suggesting that the increased RVSP, although mild, is enough to 
produce RV enlargement. Con, control; Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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A. Protein kinase C (PKC) immunoreactivity during right ventricular hypertrophy in hamsters with emphysema Figure 5
A. Protein kinase C (PKC) immunoreactivity during right ventricular hypertrophy in hamsters with emphysema. Membranous 
(Mem) and cytosolic (Cyt) fractions were prepared from hamster right ventricle. Representative immunoblots for PKC ε  and 
PKC β I demonstrate increased translocation in Emp, while PKC α  and β II were unchanged. Translocation was quantified by 
taking ratio of membrane to cytosolic levels (M:C) of each isoform. Average PKC ε  translocation index (of three separate tri-
als) was 1.14 ± 0.11 for Con (n = 5) and 2.22 ± 0.33 for Emp (n = 5) animals. B. Graph of M:C illustrates fold change normal-
ized to controls. Fold changes are averages of three separate experiments for each PKC isoform. C. Levels of total 
phosphorylated PKC ε  from whole right ventricular homogenates were unchanged among Con and Emp hamsters. *p ≤  0.05. 
Con, control; Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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this site is recognized as mature and catalytically
active[25].
Previous studies using neonatal myocytes, animals mod-
els, and transgenic mice indicate that PKC β  isoforms, par-
ticularly  β II, also are key mediators in the
pathophysiology of cardiac hypertrophy and heart failure
[12,26]. While there are no transgenic models that specif-
ically implicate PKC β I in pathogenesis of hypertrophy,
other studies have found activation to be present during
pressure overload hypertrophy in vivo [27,28]. Transloca-
tion of PKC β I may also be clinically relevant since
increased activity in PKC β  (I and II) has been reported by
Bowling et al. in failing human hearts [10]. Our data is
partially consistent with these finding as we found a sig-
nificant increase in translocation of PKC β I, but no
changes in PKC β II in hypertrophied RV of Emp hamsters.
Since previous studies using transgenic mice indicate that
PKC  β II appears to produce a heart failure phenotype
[9,12], we speculate that the lack of PKC β II translocation
in this study may due to the compensated nature of the
hypertrophied right ventricle at the time of analysis.
Taken together, our data on PKC translocation suggest
that future studies using pharmacological agents that can
selectively inhibit PKC isoforms will help confirm a spe-
cific role for PKC in this form of RVH, and give insight
into possible therapeutic interventions to limit the pro-
gression of RVH secondary to emphysema.
Levels of phospho ERK1/2 were 22% greater, along with a
34% increase in phospho ERK:total ERK in Emp com-
pared to Con. These are mild increases compared to other
in vivo studies using pressure overload imposed upon the
left ventricle [29-31]. The importance of ERK signaling has
been established in the hypertrophic response with recent
evidence supporting a role for adaptive hypertrophy and
survival as opposed to heart failure [32,33]. Given that
previous studies have reported more vigorous ERK activa-
tion in response to pressure overload, it is difficult to
determine the true physiological relevance of our ERK
data with regards to the pathogenesis of right ventricular
hypertrophy. However, it is possible that the degree of
ERK activation may fluctuate over time as hypertrophy
develops and progresses. However, a potential limitation
in our phospho PKC ε  and ERK1/2 analyses is that whole
tissue homogenates were used for experiments. Thus we
cannot assess the contribution from the non muscle frac-
tion where activation of EGF receptor and receptor tyro-
sine kinases may be operative. Another limitation is the
analysis of signal kinases after the establishment of RVH.
While these data correlate PKC β I and ε  translocation, and
EKR1/2 activation with RVH, they do not confirm these
signal kinases in mediating development RVH.
Conclusion
This study underscores the integrated nature of the cardio-
pulmonary system such that experimentally induced lung
disease significantly impacted cardiac physiology. To the
best of our knowledge, the present study is the first to have
identified activation of PKC and ERK/12 in RVH second-
ary to emphysema, and to describe the progressive nature
of alterations in the right ventricle during progression of
emphysema. Taken in context of previous studies, these
data support the hypothesis that PKC and ERK may play
an important role in the pathophysiology of RVH second-
ary to emphysema. It is also evident that after nine
months of emphysema in this model, the RV is in a com-
pensated pattern of hypertrophy with preserved systolic
function. Overall, we believe that our data regarding right
ventricular structure and function in this model of chronic
parenchymal lung disease with mild RV pressure overload
complement data from other studies of acute severe pul-
monary hypertension induced with monocrotaline. Addi-
tional studies determining status of PKC and ERK
immediately prior to the development of RVH in this
model would help further define their relevance as critical
Immunoblots of whole RV homogenates demonstrating a  34% increase in phERK1/2 to ERK1/2 ratio Figure 6
Immunoblots of whole RV homogenates demonstrating a 
34% increase in phERK1/2 to ERK1/2 ratio. Con, control; 
Emp, emphysema.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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mediators of RVH secondary to emphysema. Data from
the present study, as well as future studies, may be useful
to identify new diagnostic and treatment paradigms for
right ventricular overload.
Methods
Emphysema model
Male Syrian Golden hamsters (9 week old, 100–121 g
body weight) were maintained on a 12:12-h light-dark
cycle, and supplied with rodent chow and water ad libi-
tum. After one-week habituation period, the animals were
divided into control (Con, n = 15) and emphysema (Emp,
n = 17) groups at random. Under deep anesthesia with
ketamine/xylazine (150/7.5 mg/kg im), either saline (0.3
ml/100 g body wt) or porcine elastase [25 IU/100 g body
wt (Sigma Chemical, St. Louis, MO) in 0.3 ml of normal
saline] was instilled intratracheally using a 27-gauge
hypodermic needle as previously described [34].
Echocardiographic measurements
Parameters of cardiac structure and function were deter-
mined with transthoracic echocardiography (n = 8 con
and n = 10 Emp hamsters) as previously described
[35,36]. Hamsters were anesthetized using chloral hydrate
(300 mg/kg, intramuscularly) and the chest was shaved.
Two-dimensional and Doppler imaging were performed
using a 4.5 – 10 MHz transducer (Vivid Five, General Elec-
tric). Right ventricular internal diastolic dimension
(RVID) was measured in the apical four chamber view just
below the level of the tricuspid valve. Pulsed-wave Dop-
pler of the pulmonary outflow tract was recorded in the
parasternal short axis view at the level of the aortic valve.
The sample volume was placed proximal (3 mm) to the
pulmonary valve leaflets and aligned to maximize laminar
flow and the right ventricular outflow tract acceleration
time (RVOTAT), velocity-time integral and ejection time
were measured. Acceleration time was measured from the
onset of systolic flow to highest laminar velocity in the
spectral signal (Figure 2A). The tricuspid valve was exam-
ined for the presence of tricuspid regurgitation (TR) with
color and continuous-wave Doppler in the parasternal
short axis and apical four-chamber views. Digital images
were analyzed off-line (EchoPAC, General Electric). An
echocardiographer who was blinded to the treatment
group performed and analyzed all studies. All measure-
ments represent the means of three cardiac cycles.
Right heart catheterization
Following the final echo (nine months after elastase treat-
ment) while still under anesthesia with chloral hydrate
the right jugular vein was exposed and a temperature-cal-
ibrated 1.4 F micromanometer-tipped catheter (Millar
Instruments) was inserted into the vein and advanced in
retrograde fashion into the right ventricle. Heart rate, right
ventricular pressure and first derivative of pressure (dP/dt)
were recorded.
Tissue harvesting
Nine months following elastase injection, hamsters were
euthanized and the hearts and lungs were removed.
Whole hearts were quickly weighed and then placed in
4°C saline where the RV was dissected and weighed sepa-
rately. In a subgroup of animals (Con, n = 8; Emp n = 10)
the RVs were immediately frozen in liquid N2 and stored
separately at -80°C until further analysis. A saline dis-
placement technique was used to measure excised lung
volume at 0-cm H2O airway pressure as previously
described [37]. In addition, for each hamster, the left tibia
was dissected and the length was measured so that RV
mass and total heart mass could be normalized to the tib-
ial length as has been previously described and
validated[38].
Histological Assessment and myocyte measurements
In another subgroup of hamsters (Con, n = 7; Emp n = 5),
the hearts were rinsed in ice cold saline and then fixed by
immersion in formalin. Short axis slices from the mid wall
level of hearts were cut in 10 µM sections from paraffin
embedded tissue. Masson's trichrome-stained sections
were examined by a pathologist (blinded to the animal
identifications) and evaluated for presence of fibrosis.
Sections of RV adjacent to the portion used for histology
were subjected to a previously reported technique
designed to dissociate myocytes from fixed tissues [39].
Briefly, small pieces of the formalin-fixed RV tissue (~2 ×
2 mm) were minced and incubated for 2 h in a 50% KOH
solution (w/v made in 100 mM PBS) at 37°C. The par-
tially dissociated tissue was then placed in a 2% trypsin
solution for 3 hours and mechanically teased apart to pro-
duce mostly single myocytes. Samples were then centri-
fuged at1000 RPM for 5 min and the pellet containing
intact myocytes was recovered. Myocytes were placed on
glass slides and multiple fields from each heart were pho-
tographed with a digital camera at 20×. Right ventricular
cell surface area and perimeter length was measured using
NIH image software (V. 1.63) from 555 control and 524
Emp myocytes.
Preparation of RV homogenates for PKC immunoblotting
Cardiac lysates containing cytosolic and membrane pro-
teins were prepared from the hamster RV frozen at -80°C
as previously detailed [6]. All extraction procedures were
performed at 4°C. Protein concentration of cell fractions
were determined using a Bio Rad Protein assay (Bio-Rad,
Hercules, CA) with bovine serum albumin (BSA) as a
standard.BMC Physiology 2005, 5:6 http://www.biomedcentral.com/1472-6793/5/6
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Preparation of RV homogenates for ERK 1/2, JNK, phospho 
PKC ε , and phospho c-Raf immunoblotting
The RV was homogenized with a tissuemizer in 1 ml of
ice-cold RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1
mM sodium orthovanadate, 1 mM NaF, and 10 µl/mL
Sigma protease inhibitor cocktail (Sigma, St. Louis, MO,
cat. #P-8340)]. Samples were then sonicated twice on ice
and centrifuged at 11,000 × g for 10 mins at 4°C. Super-
natants were recovered and stored at -80°C for subse-
quent immunoblotting. Protein concentration of RV
lysate was determined using a Bio Rad Protein assay (Bio-
Rad, Hercules, CA) with bovine serum albumin (BSA) as
a standard.
Western blotting, transfer and densitometry
Electrophoresis and transfer of proteins to PVDF mem-
branes were done as previously described [6,29]. Gels
were loaded with 10 µg per lane for PKC α , β II, and ε
experiments, 20 µg per lane for PKC β II experiments, and
50 µg per lane for ERK and JNK experiments. All PKC anti-
bodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) all other antibodies / reagents were pur-
chased from Cell Signal Technology (Beverly, MA). Pri-
mary antibody directed against PKC α , β I, β II, and ε  were
incubated overnight at 4°C in a 1:1000 dilution. Antibod-
ies directed against total and phosphorylated ERK 1/2 &
JNK, phospho c-Raf, and phospho PKC ε  (recognizing
phosphorylated Ser 729) were incubated at a 1:1000 dilu-
tion for 48 h at 4°C in 5% BSA Tris buffer with 0.05%
Tween-20. Secondary antibody conjugated to horseradish
peroxidase was incubated for 1 h at 1:10,000 dilution. Sig-
nals were visualized by enhanced chemiluminescence.
Relative band density on film was measured with a scan-
ner using NIH 1.63 image software (National Institutes of
Health, Rockville, MD).
Statistical analysis
For all data except echocardiographic data, an unpaired
Student t-test was performed to detect the difference
between Emp and Con animals using SPSS V. 10 for Mac-
intosh (Chicago, IL). For changes in echocardiographic
parameters over time, a general linear model with
repeated measures was used. Pearson's correlation coeffi-
cient was used to describe the relationship among the
echocardiographic variables, hemodynamic data, and
gross anatomical measurements. Significance was
accepted at p ≤  0.05 for all tests. All values are expressed
as mean ± SD.
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